{"address1": "650 Castro Street", "address2": "Suite 450", "city": "Mountain View", "state": "CA", "zip": "94041", "country": "United States", "phone": "650 200 0412", "website": "https://www.altoneuroscience.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's product pipeline comprising ALTO-100, which is in phase 2b clinical trial for the treatment of patients with bipolar depression (BPD). It develops ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties which is in phase 2b clinical trial to treat patients with major depressive disorder (MDD); ALTO-101, a novel small molecule phosphodiesterase 4 inhibitor which is in phase 2 proof-of-concept (POC) trial for the treatment of cognitive impairment associated with schizophrenia; ALTO-203, a novel small-molecule histamine H3 receptor inverse agonist which is in phase 2 POC trial to treat patients with MDD and higher levels of anhedonia; and ALTO-202, an investigational orally bioavailable antagonist of the GluN2B subunit of the NMDA receptor which is in phase 1 clinical trial for the treatment of MDD. The company was incorporated in 2019 and is headquartered in Mountain View, California.", "fullTimeEmployees": 76, "companyOfficers": [{"maxAge": 1, "name": "Dr. Amit  Etkin M.D., Ph.D.", "age": 47, "title": "Founder, Chairman of the Board, CEO & President", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 705653, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nicholas C. Smith", "age": 35, "title": "CFO & Secretary", "yearBorn": 1989, "fiscalYear": 2023, "totalPay": 624125, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Adam  Savitz M.D., Ph.D.", "age": 58, "title": "Chief Medical Officer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 579569, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Dan  Segal B.Sc. (Hons), BCom, CA, MSc", "age": 62, "title": "Co-Founder & Strategic Advisor", "yearBorn": 1962, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael C. Hanley M.B.A.", "age": 51, "title": "Chief Operating Officer", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Erin R. McQuade J.D.", "age": 49, "title": "General Counsel & Chief Administrative Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jessica  Powell", "age": 49, "title": "Chief Development Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.16, "open": 2.16, "dayLow": 2.0, "dayHigh": 2.19, "regularMarketPreviousClose": 2.16, "regularMarketOpen": 2.16, "regularMarketDayLow": 2.0, "regularMarketDayHigh": 2.19, "payoutRatio": 0.0, "forwardPE": -0.70383275, "volume": 268437, "regularMarketVolume": 268437, "averageVolume": 300828, "averageVolume10days": 251060, "averageDailyVolume10Day": 251060, "bid": 0.0, "ask": 2.3, "bidSize": 32, "askSize": 14, "marketCap": 54685640, "fiftyTwoWeekLow": 2.0, "fiftyTwoWeekHigh": 17.55, "fiftyDayAverage": 3.3616, "twoHundredDayAverage": 7.59655, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -96599296, "profitMargins": 0.0, "floatShares": 19503574, "sharesOutstanding": 27072100, "sharesShort": 3761654, "sharesShortPriorMonth": 3984030, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.13939999, "heldPercentInsiders": 0.07481, "heldPercentInstitutions": 0.89382005, "shortRatio": 8.92, "shortPercentOfFloat": 0.1769, "impliedSharesOutstanding": 27072100, "bookValue": 5.612, "priceToBook": 0.35994297, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -61431000, "trailingEps": -2.5, "forwardEps": -2.87, "enterpriseToEbitda": 1.418, "52WeekChange": -0.85754585, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 2.02, "targetHighPrice": 18.0, "targetLowPrice": 4.0, "targetMeanPrice": 12.72333, "targetMedianPrice": 13.5, "recommendationMean": 1.28571, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 6, "totalCash": 168228992, "totalCashPerShare": 6.214, "ebitda": -68108000, "totalDebt": 16944000, "quickRatio": 16.809, "currentRatio": 16.92, "debtToEquity": 11.187, "returnOnAssets": -0.32465, "returnOnEquity": -0.55189997, "freeCashflow": -32294624, "operatingCashflow": -47424000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ANRO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -6.48149, "regularMarketPrice": 2.02, "marketState": "PRE", "fiftyDayAverageChange": -1.3416, "fiftyDayAverageChangePercent": -0.39909565, "twoHundredDayAverageChange": -5.57655, "twoHundredDayAverageChangePercent": -0.7340898, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1706884200000, "preMarketChange": -0.01999998, "preMarketChangePercent": -0.99009806, "preMarketPrice": 2.0, "regularMarketChange": -0.14, "regularMarketDayRange": "2.0 - 2.19", "fullExchangeName": "NYSE", "averageDailyVolume3Month": 300828, "fiftyTwoWeekLowChange": 0.01999998, "fiftyTwoWeekLowChangePercent": 0.00999999, "fiftyTwoWeekRange": "2.0 - 17.55", "fiftyTwoWeekHighChange": -15.529999, "fiftyTwoWeekHighChangePercent": -0.8849003, "fiftyTwoWeekChangePercent": -85.754585, "epsTrailingTwelveMonths": -2.5, "epsForward": -2.87, "corporateActions": [], "preMarketTime": 1743596856, "regularMarketTime": 1743537602, "exchange": "NYQ", "messageBoardId": "finmb_1675972978", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Alto Neuroscience, Inc.", "displayName": "Alto Neuroscience", "trailingPegRatio": null}